Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System
NCT00006132Phase 3Unknown
- Sponsor
- National Center for Research Resources
- Start
- Jun 1997
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in herpes simplex virus infection comparing Oral Acyclovir with Placebo (2 arms). Primary endpoints: Neurologic outcome improvement at 60 months, Suppression of recurrent skin lesions at 6 months and 1 more. Status: unknown.
02
Drugs
aciclovir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT00006132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006132.